CD8A and cancer: Moreover, the expression of tumor specific antigens by different ovarian cancer cell lines, such as cancer/testis antigens (CTAs), along with MHC-I molecules, can be induced by DNA hypomethylating agents, such as azacytidine, thus increasing the ability of cancer cells to be recognized by antigen-reactive CD8+ T cells [30].